Caloxin 2A1 trifluoroacetate salt
Modify Date: 2025-08-26 11:27:58
Caloxin 2A1 trifluoroacetate salt structure
|
Common Name | Caloxin 2A1 trifluoroacetate salt | ||
|---|---|---|---|---|
| CAS Number | 350670-85-8 | Molecular Weight | 1478.521 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 2095.7±65.0 °C at 760 mmHg | |
| Molecular Formula | C64H91N19O22 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 1221.3±34.3 °C | |
Use of Caloxin 2A1 trifluoroacetate saltCaloxin 2A1 is an extracellular plasma membrane Ca2+-ATPase (PMCA) peptide inhibitor. Caloxin 2A1 does not affect basal Mg2+-ATPase or Na+-K+-ATPase[1]. |
| Name | L-Valyl-L-seryl-L-asparaginyl-L-seryl-L-asparaginyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-serylglycylglycylglycinamide |
|---|---|
| Synonym | More Synonyms |
| Description | Caloxin 2A1 is an extracellular plasma membrane Ca2+-ATPase (PMCA) peptide inhibitor. Caloxin 2A1 does not affect basal Mg2+-ATPase or Na+-K+-ATPase[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Caloxin 2A1 inhibits Ca2+-Mg2+-ATPase in human erythrocyte leaky ghosts, but it does not affect basal Mg2+-ATPase or Na+-K+-ATPase in the ghosts or Ca2+-Mg2+-ATPase in the skeletal muscle sarcoplasmic reticulum. Caloxin 2A1 also inhibits Ca2+-dependent formation of the 140-kDa acid-stable acylphosphate[1]. Caloxin 2A1 increases airway smooth muscle cells (ASMCs) apoptosis[2]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 2095.7±65.0 °C at 760 mmHg |
| Molecular Formula | C64H91N19O22 |
| Molecular Weight | 1478.521 |
| Flash Point | 1221.3±34.3 °C |
| Exact Mass | 1477.658569 |
| LogP | -4.68 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.625 |
| L-Valyl-L-seryl-L-asparaginyl-L-seryl-L-asparaginyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-serylglycylglycylglycinamide |
| Glycinamide, L-valyl-L-seryl-L-asparaginyl-L-seryl-L-asparaginyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-serylglycylglycyl- |